
|Videos|November 24, 2020
Marie E. McDonnell, MD: The Latest in Diabetes Management
An endocrinologist from Brigham and Women’s Hospital discusses the latest in diabetes management.
Advertisement
Few fields have experienced the growth in therapies and technologies as diabetes management in recent years. With such an explosion in therapies and constant growth in diabetes technology, picking and choosing what approaches are most appropriate for each patient has become a unique situation.
For more on the topic, check out this interview with Marie E. McDonnell, MD, an endocrinologist and director of the Brigham Diabetes Program at Brigham and Women’s Hospital and a lecturer on medicine at Harvard Medical School, from Medical Economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD
4
What Comes Next for Berobenatide? VESPER-3 and Phase 3 Expectations, With John Buse, MD, PhD
5


























































